The 3rd Study Session hosted by the Intestinal Flora Transplantation Clinical Study Group was held.
On Sunday, January 28, 2018, the 3rd Study Session sponsored by the Intestinal Flora Transplantation Clinical Study Group was held. We had participants from Tokyo, Kumamoto, and Aichi, and had a lively exchange of opinions. We would like to take this opportunity to thank everyone who attended. The study session covered topics such as “immunity,” “depression and intestinal bacteria,” “nutritional therapy,” and “intestinal flora transplantation,” which are essential for patients’ mental and physical health. Study Session
Facilitated by Dr. Masahiko Shirotani (Luke’s Ashiya Clinic: Hyogo, Japan)
Mr. Makoto Shimizu (Symbiosis LLC)
We showed the lab to those attending for the first time.
There were also greetings from Symbiosis LLC and laboratory staff.
With each successive issue, I see more and more possibilities for intestinal flora, such as a mechanism for sharing information and protocols for writing papers in order for multiple medical institutions to undergo transplantation in the future. Thank you for your continued support. その他の Notices and Activity Reports に関する記事
Articles about other Notices and Activity Reports

November 16, 2026
10th Scientific Conference of the Association for Clinical Research of Fecal Microbiota Transplantation Japan [Event Report]
The Association for Clinical Research of Fecal Microbiota Transplantation Japan (General Incorporated Foundation) held its 10th Scientific Conference on Sunday, 27 September 2026. At this milestone 10th conference, we presented the latest findings and clinical data on “NanoGAS®-FMT” across a wide range of clinical fields, including cancer, gastroenterology, neurodevelopmental disorders and endoscopic examinations, for those […]

October 06, 2026
Survey Summary from the 10th Annual Academic Conference
The 10th Annual Academic Conference was held on September 27, 2026.The event was conducted in a hybrid format, both on-site and online, with close to 150 participants in total, including healthcare professionals, corporate representatives, research institution staff, and even patients, their families, and members of the general public. In this article, we share the results […]

October 28, 2024
〈Clinical Trial〉Completion Report
We are pleased to report the completion of the specified clinical trial titled “Specified Clinical Trial on the Efficacy and Safety of a Novel Fecal Microbiota Transplantation Method for Autism Spectrum Disorder,” which was initiated by our research group in May 2023. This specified clinical trial is published on the jRCT (Japan Registry of Clinical […]